Greenland Mines Ltd
GRML GRMLWCIK 0001907223 · Biological Products, (No Diagnostic Substances) · Nasdaq, Nasdaq
- Klotho Neurosciences, Inc. (until 2026-03-10)
- ANEW Medical, Inc. (until 2024-09-18)
- Redwoods Acquisition Corp. (until 2024-06-21)
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$23.08M
−71.6% YoY
Q1 May 2026
EPS Diluted (TTM)
−$0.40
+31.3% YoY
Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$10M
Q1 May 2026
Total Debt
$300K
Q1 May 2026
Shares Outstanding
121.24M sh
Q1 May 2026
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.
Balance Sheet
Cash vs Debt
Latest news
All news →-
High Neutral
Greenland Mines (GRML) Enters Private Stock Sale Agreement
Greenland Mines Ltd signed a Securities Purchase Agreement on June 15, 2026, to sell shares of its common stock at $0.25 per share in a private offering.